Interleukin-6 activates arginine vasopressin neurons in the supraoptic nucleus during immune challenge in rats
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The increase of plasma arginin-vasopressin (AVP) release, which translates hypothalamic AVP neuron activation in response to immune challenge, appears to occur independently of plasma osmolality or blood pressure changes. Many studies have shown that major inflammatory mediators produced in response to peripheral inflammation, such as prostaglandin (PG)-E 2 and interleukin (IL)-1β, excite AVP neurons. However, in vivo electrical activation of AVP neurons was still not assessed in relation to plasma AVP release, osmolality, or blood pressure or to the expression and role of inflammatory molecules like PG-E 2, IL-1β, IL-6, and tumor necrosis factor-α (TNFα). This study aims at elucidating those factors that underlie the activation of AVP neurons in response to immune stimulation mimicked by an intraperitoneal injection of lipopolysaccharide (LPS) in male Wistar rats. LPS treatment concomittanlty decreased diuresis and increased plasma AVP as well as AVP neuron activity in vivo, and these effects occurred as early as 30 min. Activation was sustained for more than 6 h. Plasma osmolality did not change, whereas blood pressure only transiently increased during the first hour post-LPS. PG-E 2, IL-1β, and TNFα mRNA expression were raised 3 h after LPS, whereas IL-6 mRNA level increased 30 min post-LPS. In vivo electrophysiological recordings showed that brain IL-6 injection increased AVP neuron activity similarly to peripheral LPS treatment. In contrast, brain injection of anti-IL-6 antibodies prevented the LPS induced-activation of AVP neurons. Taken together, these results suggest that the early activation of AVP neurons in response to LPS injection is induced by brain IL-6.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504 · cited 1×
“IL-1 is also excitatory, as attested by the increase in AVP concentration in the portal blood of anesthetized rats (43) and in the plasma of conscious, freely moving rats (39) following intravenous (iv) injection of IL-1 .”
BackgroundAstrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304 · cited 16×
“We studied the expression of several inflammatory mediators likely to affect directly the activity of AVP neurons after LPS treatment, in particular prostanoids like PG-E2 (3, 15, 31) and cytokines such as IL-1 , IL-6, or TNF (11, 13, 23).”
BackgroundInfluentialStimulus-transcription coupling in neurons: role of cellular immediate-early genes
Morgan, J. I., & Curran, T. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90096-9 · Cited by 969 · cited 2×
“To assess activation of SON neurons, we measured the expression of c-fos proto-oncogene mRNA and its product (8, 38).”
MethodLayé, S., Parnet, P., Goujon, E., & Dantzer, R. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90197-x · Cited by 500 · cited 15×
“We studied the expression of several inflammatory mediators likely to affect directly the activity of AVP neurons after LPS treatment, in particular prostanoids like PG-E2 (3, 15, 31) and cytokines such as IL-1 , IL-6, or TNF (11, 13, 23).”
BackgroundInfluentialMastorakos, G., Weber, J. S., Magiakou, M. A., Gunn, H., & Chrousos, G. P. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962300 · Cited by 290 · cited 3×
“other hand, IL-1 and IL-6 induced AVP release (29, 34, 39), and IL-1 stimulated the activity of AVP neurons (33).”
BackgroundGatti, S., & Bartfai, T. (1993) · Brain Research · doi:10.1016/0006-8993(93)90090-a · Cited by 257
Cited by
Neuroinflammation: The Devil Is in the Details
DiSabato, D. J., Quan, N., & Godbout, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13607 · Cited by 1,640
“Induction of an immune response with peripheral LPS administration 28 days after ON crush significantly increased expression of IL-1b, TNF-a, and IL-6 (Palin et al. 2009).”
Neuronal regulation of immunity: why, how and where?
Schiller, M., Ben-Shaanan, T. L., & Rolls, A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-0387-1 · Cited by 264
Marital behavior, oxytocin, vasopressin, and wound healing
Gouin, J.-P., Carter, C. S., Pournajafi-Nazarloo, H., Glaser, R., Malarkey, W. B., Loving, T. J., Stowell, J., & Kiecolt-Glaser, J. K. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.01.009 · Cited by 227
“In rodents, injection of lipopolysaccharide (LPS) and intracerebral infusion of IL-1b increased the release of central and peripheral oxytocin and vasopressin (Landgraf et al., 1995; Rivest and Laflamme, 1995; Palin et al., 2009).”
BackgroundA common neuroendocrine substrate for diverse general anesthetics and sleep
Jiang-Xie, L.-F., Yin, L., Zhao, S., Prevosto, V., Han, B.-X., Dzirasa, K., & Wang, F. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.033 · Cited by 173
“Previous studies had demonstrated that endogenous somnogen prostaglandin D2 (PGD2) and interleukin-6 could strongly activate SON neurons (Palin et al., 2009; Scammell et al., 1998).”
Donegan, J. J., Girotti, M., Weinberg, M. S., & Morilak, D. A. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3968-13.2014 · Cited by 77
Metadata
- Authors
- Palin, K., Moreau, M. L., Sauvant, J., Orcel, H., Nadjar, A., Duvoid-Guillou, A., Dudit, J., Rabié, A., & Moos, F.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2009-06
- Volume
- 296
- Issue
- 6
- Pages
- E1289-E1299
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2123900319
- Cited by
- 73
- References
- 6
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.